Drug Development Technology is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More X
X

Zepatier for the Treatment of Chronic Hepatitis C Genotype 1 and 4 Infection

Drug (Brand / Generic)

Zepatier (elbasvir and grazoprevir)

Company

Merck

Current Indication

Hepatitis c virus gentotype 1 and 4 infection

Market Sector

Anti-Infective

Development Status

Approved in the US
Expand

Go Top